TCR-engineered T Cells in Solid Tumors: IMA202-101
Clinical trial NCT03441100 · COMPLETED
Trial details
- NCT number
- NCT03441100
- Sponsor
- Immatics US, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-02
- Primary completion
- 2022-06-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.